British pharmaceutical deal with the
Photo: Oded Balilty AP/TT

British pharmaceutical deal with the US underway

The UK is expected to present a deal with the Trump administration on duty-free pharmaceutical exports to the US, Bloomberg reports.

Advertisement

The agreement that is underway also includes reduced discounts that drug manufacturers are forced to accept in a system applied by the British NHS medicines authority.

According to the news agency, the settlement will be presented on Monday evening.

Britain – where, among other things, Swedish-British Astra Zeneca is located – has, according to Bloomberg's anonymous sources, agreed to set a cap on discounts of 15 percent, down from the current cap of 23 percent.

A trade barrier in the form of a threshold for what is considered a cost-effective medicine will simultaneously be lifted by around 25 percent.

AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All